vrtx.com - VRTX Profit before deduction of interest, taxes, depreciation and amortization

Public company logo of Vertex (VRTX)

Historical EBITDA_Co data on the GURU.Markets website clearly demonstrate the efficiency of Vertex Pharmaceuticals (VRTX) robotic molecule screening. Dominance in cystic fibrosis therapy ensures capital inflow, while the use of third-party contractors for testing optimizes expenses. The value of 4834.54 serves as the current parameter value, allowing the investor to distinguish real cash flow from speculative growth in share prices.

vrtx.com (VRTX) Operating profit EBITDA: for the period 11/23/2025 - 11/11/2026

Summary analytical data breakdowns for Vertex (VRTX)

- stock value and consensus price forecast:
Market Chart Vertex Corp|VRTX - Consensus Target
- issuer market value details:
Market Valuation Vertex Pharmaceuticals|VRTX - Enterprise Value
- book capitalization indicators:
Net Asset Value per Share Vertex Pharmaceuticals|VRTX - Book Capitalization|Capitalization to Book Value Ratio vrtx.com|VRTX - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Vertex Pharmaceuticals|VRTX - Long-Term Debt to Equity|Current Liabilities to Equity Vertex Pharmaceuticals Incorporated|VRTX - Company Aggregate Debts|Debt to Net Assets Ratio Vertex Pharmaceuticals|VRTX - Company Long-Term Debts|Company Short-Term Debts Vertex Pharmaceuticals|Intermediate Coverage Ratio vrtx.com
- earnings and market multiples details:
VRTX - Company Net Income|Future Profit Vertex Pharmaceuticals|VRTX - P/E Multiple|Forward P/E Multiple vrtx.com|VRTX - Price/Earnings to Growth Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Vertex Pharmaceuticals|VRTX - Operating profit EBITDA|Net earnings per one share for the last twelve months Vertex Pharmaceuticals|VRTX - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months vrtx.com|VRTX - Net earnings per share growth this year|Projected earnings per share increase next year Vertex Pharmaceuticals
Summary company analytics:Vertex Corp
Brand item of vrtx.com

Investors must assess the fundamental quality resilience of Vertex Pharmaceuticals (VRTX) through cash flow analysis. This metric measures daily operating income before interest and taxes, reflecting the actual efficiency of the business. The trend in EBITDA_Co allows for an accurate capture of the company's reaction to market stress. The stability of this indicator confirms the biotech giant's ability to finance costly laboratory upgrades to meet ESG standards. Energy-saving technologies reduce costs, thereby supporting operating profit.

Who Vertex Pharmaceuticals competes with

Operating income before deduction of amortization Alnylam Corp (ALNY)|INSM: Operating profit before deduction of amortization|Profit before deduction of interest, taxes, depreciation and amortization UTHR|BMRN: Operating profit EBITDA|Profit before interest, taxes and amortization BridgeBio Pharma (BBIO)|BGM (BGM Group Limited) - Operating profit EBITDA|Operating profit before amortization COGT (Cogent Corp)|Operating profit before deduction of amortization XERS (Xeris Biopharma)|KROS (kerostx.com) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Arcturus Therapeutics Holdings Inc. ARCT|ETON (Eton Pharmaceuticals Inc) - Profit before deduction of interest, taxes, depreciation and amortization|Kamada Corp - Operating profit EBITDA|Income before deduction of interest, taxes and amortization FULC (Fulcrum Corp)|ABEO: Operating profit EBITDA|Mereo BioPharma Group plc (MREO) - Operating profit EBITDA|Profit before payment of interest, taxes and amortization Protalix BioTherapeutics, Inc.|PLRX: Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Applied Therapeutics (APLT)|Operating profit before deduction of amortization Aileron Therapeutics RNTX|Operating profit EBITDA GELS (Gelteq)|Operating profit EBITDA Aytu BioPharma Inc AYTU|CMMB: Operating profit before deduction of amortization|SRXH: Profit before payment of interest, taxes and amortization|PLRZ: Operating profit EBITDA|Profit before interest, taxes and amortization Aeterna Zentaris Inc. (AEZS)|Profit before payment of interest, taxes and amortization Cyclo Therapeutics|INZY: Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization RPHM (Reneo Pharmaceuticals, Inc.)|Company profit before taxes, interest and amortization CSCI